Herein, starting from a retrospective cohort analysis, and performing a deep investigation of the phenotypic and molecular effects of KDM1A silencing in human primary tumor-derived CRC-SCs and, for comparison, in adherent cells, we investigated KDM1A as a possible prognostic and therapeutic target in CRC. The gene discussed is KDM1A; the disease is neoplasm.